By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS


Industry
Pharmaceutical






Company News
Enanta Pharmaceuticals, Inc. Announces The Appointment Of Dr. Lesley Russell To Its Board Of Directors 11/22/2016 10:42:47 AM
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Fourth Quarter And Year Ended September 30, 2016 11/22/2016 10:25:22 AM
Enanta Pharmaceuticals, Inc. Announces Abbvie’s Investigational, Pan-Genotypic Regimen Of Glecaprevir/Pibrentasvir (G/P) Shows High SVR Rates In Chronic Hepatitis C Patients With Severe Chronic Kidney Disease 11/15/2016 11:15:20 AM
Enanta Pharmaceuticals, Inc. Announces Eight Weeks Of Treatment With AbbVie (ABBV)’s Investigational, Pan-Genotypic Regimen Of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR Rates Across All Major Genotypes Of Chronic Hepatitis C 11/11/2016 11:48:34 AM
Enanta Pharmaceuticals, Inc. Announces New Data On FXR Agonist EDP-305 For Non-Alcoholic Steatohepatitis (NASH) At The Liver Meeting 2016 11/11/2016 11:44:06 AM
Enanta Pharmaceuticals, Inc. To Host Conference Call On November 21 At 4:30 P.M. ET To Discuss Financial Results For Its Fiscal Fourth Quarter And Year Ended September 30, 2016 11/1/2016 11:53:40 AM
Enanta Pharmaceuticals, Inc. Announces New Data Presentations at The Liver Meeting 2016 10/3/2016 11:19:31 AM
Enanta Pharmaceuticals, Inc. Presents Data On A Novel Non-Fusion Inhibitor Of Respiratory Syncytial Virus (RSV) At The 10th Annual Respiratory Syncytial Virus Conference 9/30/2016 4:05:19 PM
Enanta Pharmaceuticals, Inc. Initiates Phase 1 Clinical Study Of EDP-305, Its Lead FXR Agonist For The Treatment Of Non-Alcoholic Steatohepatitis (NASH) 9/29/2016 8:55:56 AM
Enanta Pharmaceuticals, Inc. Announces Data On Eight-Week Treatment Of AbbVie (ABBV)’s VIEKIRAX (Ombitasvir/Paritaprevir/Ritonavir Tablets) + EXVIERA (Dasabuvir Tablets) In Patients With Genotype 1b Chronic Hepatitis C 9/23/2016 9:31:01 AM
12345678910...
//-->